Aflac Incorporated (AFL)

Market Cap	57.76B
Revenue (ttm)	16.89B
Net Income (ttm)	3.59B
Shares Out	542.49M
EPS (ttm)	6.44
PE Ratio	16.52
Forward PE	15.42
Dividend	$2.32 (2.18%)
Ex-Dividend Date	May 21, 2025

Volume	1,052,870
Open	104.76
Previous Close	105.53
Day's Range	104.76 - 106.48
52-Week Range	83.27 - 115.50
Beta	0.83
Analysts	Hold
Price Target	104.07 (-2.25%)
Earnings Date	Apr 30, 2025

About AFL

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products t...

• Industry: Insurance - Life
• Sector: Financials
• Founded: 1955
• Employees: 12,694
• Stock Exchange: NYSE
• Ticker Symbol: AFL
• Website: https://www.aflac.com

Financial Performance

In 2024, Aflac's revenue was $18.93 billion, an increase of 1.21% compared to the previous year's $18.70 billion. Earnings were $5.44 billion, an increase of 16.83%.

Analyst Forecast

According to 14 analysts, the average rating for AFL stock is "Hold." The 12-month stock price forecast is $104.07, which is a decrease of -2.25% from the latest price.

Price Target

$104.07

(-2.25% downside)

Analyst Consensus: Hold